Literature DB >> 2175709

Oral treatment with itraconazole of aspergilloma in cavitary lung cancer.

N Impens1, J De Greve, K De Beule, M Meysman, S De Beuckelaere, W Schandevyl.   

Abstract

We report a case of aspergilloma in a necrotic small cell lung cancer, where poor pulmonary function and performance status of the patient precluded surgical treatment. High dose Itraconazole, a new oral anti-mycotic drug, was given for 13 months. During this treatment there was a decrease of the fungus ball size and no haemoptysis. Moreover control of the aspergilloma allowed chemotherapeutic treatment of the underlying bronchocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175709

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  Itraconazole concentrations in airway fluid and tissue.

Authors:  D N Watkins; N R Badcock; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

2.  Two cases of endobronchial aspergilloma with lung cancer: a review the literature of endobronchial aspergilloma with underlying malignant lesions of the lung.

Authors:  Shenghua Jiang; Luning Jiang; Fenglian Shan; Xiulian Zhang; Ming Song
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Non-small cell lung cancer coexisting with pulmonary aspergilloma.

Authors:  Hideki Itano; Akio Andou; Hiroshi Date; Nobuyoshi Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-09

Review 4.  [Lung cavities, mycetomas and hemoptysis].

Authors:  Wolfgang Domej; Josef Hermann; Robert Krause; Martin Wehrschütz; Alfred Maier; Erich Flögel
Journal:  Wien Med Wochenschr       Date:  2007

5.  Risk factors of severe hemoptysis in patients with fungus ball.

Authors:  Tae Hoon Kim; Hyun Jung Koo; Chae-Man Lim; Sang-Bum Hong; Jin Won Huh; Kyung Wook Jo; Tae Sun Shim; Woo Sung Kim; Younsuck Koh
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.